We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Mediclinic International Plc | LSE:MDC | London | Ordinary Share | GB00B8HX8Z88 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 501.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMMDC
RNS Number : 5677X
Mediclinic International PLC
22 February 2017
Mediclinic International plc
(Incorporated in England and Wales)
Company Number 8338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
("Mediclinic" or "the Company")
22 February 2017
DIRECTORATE CHANGE
The Company announces that Mr Ian Tyler, the Company's Senior Independent Director, resigned as a director of the Company with effect from 21 February 2017.
Ian Tyler was appointed as an independent non-executive director and Chairman of Al Noor Hospitals Group plc ("Al Noor") on 5 June 2013 prior to its successful IPO and listing on the London Stock Exchange on 21 June 2013. In 2015 he was instrumental in leading this group through the combination with Mediclinic International Limited. Subsequent to the combination, he was appointed as the Senior Independent Director of Mediclinic International plc on 15 February 2016.
Mr Desmond Smith has been appointed as the Senior Independent Director, in the place of Ian Tyler. Desmond Smith was appointed an independent non-executive director of Mediclinic International Limited in 2008 and Lead Independent Director in 2010. He was appointed an independent non-executive director of the Company subsequent to the combination of Al Noor and Mediclinic International Limited. Desmond Smith is Chairman of Mediclinic's Audit and Risk Committee and a member of the Nomination Committee. He is also Chairman of the Sanlam Group and the Reinsurance Group of America (South Africa).
This announcement is made in accordance with the requirement of LR 9.6.11.
Mediclinic's primary listing is on the Main Market of the LSE, with secondary listings on the JSE in South Africa and on the NSX in Namibia.
Registered address: 1(st) Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom
Website: www.mediclinic.com
Corporate broker: Morgan Stanley & Co International plc
JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
For further information please contact:
Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
Capita Company Secretarial Services Limited
Victoria Dalby
+44 (0)207 954 9600
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOAPGUUCPUPMGGP
(END) Dow Jones Newswires
February 22, 2017 07:00 ET (12:00 GMT)
1 Year Mediclinic Chart |
1 Month Mediclinic Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
